Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma
Version of Record online: 6 MAR 2014
© 2014 Wiley Periodicals, Inc.
Volume 32, Issue 1, pages 153–154, January/February 2015
How to Cite
West, E. S., Williams, V. L. and Morelli, J. G. (2015), Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma. Pediatric Dermatology, 32: 153–154. doi: 10.1111/pde.12316
- Issue online: 21 JAN 2015
- Version of Record online: 6 MAR 2014
Neutrophilic panniculitis is a rare adverse effect of therapy with selective BRAF inhibitors. We report a case of neutrophilic panniculitis in a 15-year-old girl receiving treatment with vemurafenib for a brainstem glioma. Clinicians should be aware of this rare but important side effect of vemurafenib. This is the first report of neutrophilic panniculitis in a child treated with vemurafenib.